AAAAAA

   
Results: 1-19 |
Results: 19
HODGKINS-DISEASE IN THE ELDERLY - ANALYSIS ON A LARGE GROUP OF PATIENTS 65 YEARS AND OLDER
Authors: LEVIS A BOTTO B DEPAOLI L BERTINI M BARALDI A GALLAMINI A GAVAROTTI P PINI M SALVI F SCASSA E TERMINE G VITOLO U
Citation: A. Levis et al., HODGKINS-DISEASE IN THE ELDERLY - ANALYSIS ON A LARGE GROUP OF PATIENTS 65 YEARS AND OLDER, Annals of oncology, 9, 1998, pp. 118-118
LONG-TERM ADMINISTRATION OF G-CSF DOES NOT INCREASE AT 5 YEARS THE RISK OF CYTOGENETIC ABNORMALITIES IN PATIENTS WITH SEVERE APLASTIC-ANEMIA
Authors: BACIGALUPO A BROCCIA G CORDA G ARCESE W DIBONA E CAROTENUTO M GALLAMINI A LOCATELLI F MORI P SARACCO P TODESCHINI G COSER P IACOPINO P VANLINT MT
Citation: A. Bacigalupo et al., LONG-TERM ADMINISTRATION OF G-CSF DOES NOT INCREASE AT 5 YEARS THE RISK OF CYTOGENETIC ABNORMALITIES IN PATIENTS WITH SEVERE APLASTIC-ANEMIA, Experimental hematology, 26(8), 1998, pp. 235-235
IDARUBICIN IN PATIENTS WITH DIFFUSE LARGE-CELL LYMPHOMAS - A RANDOMIZED TRIAL COMPARING VACOP-B (A=DOXORUBICIN) VS VICOP-B (I=IDARUBICIN)
Authors: BERTINI M FREILONE R BOTTO B CALVI R GALLAMINI A GATTI AM LIBERATI AM MENEGHINI V ORLANDI E ORSUCCI L PIZZUTI M SCALABRINI DR SALVI F TODESCHINI G VITOLO U RESEGOTTI L
Citation: M. Bertini et al., IDARUBICIN IN PATIENTS WITH DIFFUSE LARGE-CELL LYMPHOMAS - A RANDOMIZED TRIAL COMPARING VACOP-B (A=DOXORUBICIN) VS VICOP-B (I=IDARUBICIN), Haematologica, 82(3), 1997, pp. 309-313
REVISITING THE PROGNOSTIC ROLE OF GALLIUM SCINTIGRAPHY IN LOW-GRADE NON-HODGKINS-LYMPHOMA
Authors: GALLAMINI A BIGGI A FRUTTERO A PUGNO F CAVALLERO G PREGNO P GRASSO M FARINELLI C LEONE A GALLO E
Citation: A. Gallamini et al., REVISITING THE PROGNOSTIC ROLE OF GALLIUM SCINTIGRAPHY IN LOW-GRADE NON-HODGKINS-LYMPHOMA, European journal of nuclear medicine, 24(12), 1997, pp. 1499-1506
CAUSES OF DEATH IN A LARGE GROUP OF PATIENTS TREATED FOR HODGKINS-DISEASE (HD)
Authors: LEVIS A SALVI F DEPAOLI L BOTTO B RICARDI U BERTINI M GALLAMINI A GAVAROTTI P NOVARINO A CAMBRIN GR SCALABRINI DR TERMINE G VITOLO U
Citation: A. Levis et al., CAUSES OF DEATH IN A LARGE GROUP OF PATIENTS TREATED FOR HODGKINS-DISEASE (HD), Blood, 90(10), 1997, pp. 3922-3922
PROGNOSTIC RELEVANCE OF IRREVERSIBLE RENAL-FAILURE IN MULTIPLE-MYELOMA (MM)
Authors: DIVISTARINO MPG BONFERRONI M CANEPARI G CENTO G GALLAMINI A GALLO E GUARNIERI A GRASSO M GHEZZI PM MARAZZI F REMUZZI G
Citation: Mpg. Divistarino et al., PROGNOSTIC RELEVANCE OF IRREVERSIBLE RENAL-FAILURE IN MULTIPLE-MYELOMA (MM), Journal of the American Society of Nephrology, 7(9), 1996, pp. 708-708
COMBINED-MODALITY TREATMENT WITH A WEEKLY BRIEF CHEMOTHERAPY (ACOP-B)FOLLOWED BY LOCOREGIONAL RADIOTHERAPY IN LOCALIZED-STAGE INTERMEDIATE-GRADE TO HIGH-GRADE NON-HODGKINS-LYMPHOMA
Authors: FREILONE R BOTTO B VITOLO U BERTINI M AUDISIO E CALVI R CUCCHI M DECRESCENZO A GALLAMINI A GHIO R GRISO L LEVIS A MASSARA G ORSUCCI L RICARDI U SCALABRINI DR SALVI F SECONDO V RESEGOTTI L
Citation: R. Freilone et al., COMBINED-MODALITY TREATMENT WITH A WEEKLY BRIEF CHEMOTHERAPY (ACOP-B)FOLLOWED BY LOCOREGIONAL RADIOTHERAPY IN LOCALIZED-STAGE INTERMEDIATE-GRADE TO HIGH-GRADE NON-HODGKINS-LYMPHOMA, Annals of oncology, 7(9), 1996, pp. 919-924
RESULTS OF A LOW AGGRESSIVITY CHEMOTHERAPY REGIMEN (CVP CEB) IN ELDERLY HODGKINS-DISEASE PATIENTS/
Authors: LEVIS A DEPAOLI L BERTINI M BOTTO B CIRAVEGNA G FREILONE R GALLAMINI A GAVAROTTI P RICARDI U SCALABRINI DR SALOMONE A SALVI F VITOLO U PILERI A SANNAZZARI GL RESEGOTTI L
Citation: A. Levis et al., RESULTS OF A LOW AGGRESSIVITY CHEMOTHERAPY REGIMEN (CVP CEB) IN ELDERLY HODGKINS-DISEASE PATIENTS/, Haematologica, 81(5), 1996, pp. 450-456
INTESTINAL T-CELL LYMPHOMA WITH MASSIVE TISSUE AND BLOOD EOSINOPHILIAMEDIATED BY IL-5
Authors: GALLAMINI A CARBONE A LISTA P CAVALLERO G REATO G FRUTTERO A NOVERO D ASNAGHI G DICELLE PF FOA R
Citation: A. Gallamini et al., INTESTINAL T-CELL LYMPHOMA WITH MASSIVE TISSUE AND BLOOD EOSINOPHILIAMEDIATED BY IL-5, Leukemia & lymphoma, 17(1-2), 1995, pp. 155-161
GA-67 SCAN IN LOW-GRADE NON-HODGKIN LYMPHOMAS - RELATIONSHIP WITH CD71 EXPRESSION AND PROGNOSIS
Authors: GALLAMINI A BIGGI A CAVALLERO GB PREGNO P GRASSO M FRUTTERO A CAMUZZINI GF GALLO E
Citation: A. Gallamini et al., GA-67 SCAN IN LOW-GRADE NON-HODGKIN LYMPHOMAS - RELATIONSHIP WITH CD71 EXPRESSION AND PROGNOSIS, Blood, 86(10), 1995, pp. 3236-3236
ANTILYMPHOCYTE GLOBULIN, CYCLOSPORINE, AND GRANULOCYTE-COLONY-STIMULATING FACTOR IN PATIENTS WITH ACQUIRED SEVERE APLASTIC-ANEMIA (SAA) - APILOT-STUDY OF THE EBMT SAA WORKING PARTY
Authors: BACIGALUPO A BROCCIA G CORDA G ARCESE W CAROTENUTO M GALLAMINI A LOCATELLI F MORI PG SARACCO P TODESCHINI G COSER P IACOPINO P VANLINT MT GLUCKMAN E
Citation: A. Bacigalupo et al., ANTILYMPHOCYTE GLOBULIN, CYCLOSPORINE, AND GRANULOCYTE-COLONY-STIMULATING FACTOR IN PATIENTS WITH ACQUIRED SEVERE APLASTIC-ANEMIA (SAA) - APILOT-STUDY OF THE EBMT SAA WORKING PARTY, Blood, 85(5), 1995, pp. 1348-1353
SCLERODERMA AND HAIRY-CELL LEUKEMIA
Authors: CAVALLERO GB BONFERRONI M GALLAMINI A GRASSO M CARBONE A
Citation: Gb. Cavallero et al., SCLERODERMA AND HAIRY-CELL LEUKEMIA, European journal of haematology, 52(3), 1994, pp. 189-190
PROBABILITY OF CURE IN ELDERLY HODGKINS-DISEASE PATIENTS
Authors: LEVIS A DEPAOLI L URGESI A BERTINI M ORSUCCI L VITOLO U BUCHI G GALLAMINI A GAVAROTTI P NOVARINO A SCALABRINI DR MAZZA U PILERI A SANNAZZARI GL RESEGOTTI L
Citation: A. Levis et al., PROBABILITY OF CURE IN ELDERLY HODGKINS-DISEASE PATIENTS, Haematologica, 79(1), 1994, pp. 46-54
INTERFERON ALFA-2A AS COMPARED WITH CONVENTIONAL CHEMOTHERAPY FOR THETREATMENT OF CHRONIC MYELOID LEUKEMIA
Authors: TURA S BACCARANI M ZUFFA E RUSSO D ZACCARIA A FIACCHINI M TESTONI N ZAMAGNI MD MARTINELLI G DAMIANI D MICHIELI M FOWST C HOLDENER EE SPECCHIA G LISO V MORRA E BERNASCONI C ALIMENA G MANDELLI F LEONI P DANIELI G NOSARI A DECATALDO F MAJOLINO I CARONIA F LIBERATI AM GRIGNANI F TABILIO A MARTELLI M PAOLINO F RESEGOTTI L DITUCCI A BROCCIA G LEONI F CIOLLI S LUCIANO L ROTOLI B PERRICONE R CAJOZZO A MONTUORO A DELAURENZI A VOLPE E DEMILIO A BATTISTA R CAPUCCI A IZZI T SCAPOLI GL CASTOLDI GL LOMBARDO M TORLONTANO G LANDOLFI R LEONE G DELFINI C SPARAVENTI G PAPINESCHI F SPREMOLLA G RISSO M MARMONT AM DINI D DIPRISCO U MANGONI L RIZZOLI V GIRINO M ASCARI E BODENIZZA CA CAROTENUTO M DIFRANCESCO A QUAGLINO D NARDELLI S CICCONE F MIRAGLIA E DEBIASE R GALLO E PILERI A RAMBALDI A BARBUI T MORANDI S BIANCHINI E DEROSA C CIMINO R RONCA F NOBILE F CANTONETTI M PAPA G GALLAMINI A BUFFA F MUSOLINO C SQUADRITO G CAPALDI A GIOVANNELLI E PINOTTI G VENCO A ZAGONEL V PINTO A GENTILINI I COSER P GUGLIELMO P CACCIOLA E PIZZUTI M RICCIUTI F FANIN R CRISCUOLO D MONTEFUSCO E
Citation: S. Tura et al., INTERFERON ALFA-2A AS COMPARED WITH CONVENTIONAL CHEMOTHERAPY FOR THETREATMENT OF CHRONIC MYELOID LEUKEMIA, The New England journal of medicine, 330(12), 1994, pp. 820-825
GA-67 AND CLINICAL OUTCOME IN LYMPHOMA WITH LARGE MASSES
Authors: CAVALLERO GB BONFERRONI M BIGGI A LEONE A GALLAMINI A GRASSO M PREGNO P PELISSERO A CAMUZZINI G GALLO E
Citation: Gb. Cavallero et al., GA-67 AND CLINICAL OUTCOME IN LYMPHOMA WITH LARGE MASSES, Blood, 84(10), 1994, pp. 10000639-10000639
SELECTIVE OVERSHOOT OF PH-NEGATIVE BLOOD HEMATOPOIETIC-CELLS AFTER INTENSIVE IDARUBICIN-CONTAINING REGIMEN AND THEIR REPOPULATING CAPACITY AFTER REINFUSION
Authors: CARELLA AM PODESTA M FRASSONI F PUNGOLINO E POLLICARDO N RAFFO MR FERRERO R BENVENUTO F FIGARI O GIORDANO D LERCARI G CARLIER P VALBONESI M VITALE V PARODI M GALLAMINI A SAGLIO G MARMONT AM
Citation: Am. Carella et al., SELECTIVE OVERSHOOT OF PH-NEGATIVE BLOOD HEMATOPOIETIC-CELLS AFTER INTENSIVE IDARUBICIN-CONTAINING REGIMEN AND THEIR REPOPULATING CAPACITY AFTER REINFUSION, Stem cells, 11, 1993, pp. 67-72
WILL MOLECULAR-BIOLOGY CONTRIBUTE TO REFINE PROGNOSIS AND TO SELECT TREATMENT
Authors: ZACCARIA A MARTINELLI G BUZZI M FARABEGOLI P SAGLIO G GUERRASIO A BERNABEI PA SANTINI V PELLICCI PG MENCARELLI A COCO FL DIVERIO D RAMBALDI A SANTORO A TURA S RUSSO D ZUFFA E FANIN R PATRIARCA F FIACCHINI M BACCARANI M TESTONI N ZAMAGNI MD ZACCARIA A MONTEFUSCO E ALIMENA G MELONI G MANDELLI F DAMIANI D MICHIELI M CRISCUOLO D FOWST C HOLDENER EE SPECCHIA G LISO V MORRA E BERNASCONI C DEMILIO A BATTISTA R DITUCCI A BROCCIA G MAIOLINO I CARONIA F LUCIANO L ROTOLI B LEONI P DANIELI G BODENIZZA CA CAROTENUTO M ROTONDO SG NOSARI A DECATALDO F MONTUORO A DELAURENZI A CAMILLO S LIBERATI AM GRIGNANI F TABILIO A MARTELLI M RAMBALDI A BARBUI T LEONI F CIOLLI S RONCA F NOBILE F PAOLINO F RESEGOTTI L PAPINESCHI F SPREMOLLA G LANDOLFI R LEONE G VOLPE E MANGONI L RIZZOLI V CAPUCCI A IZZI T SCAPOLI GL CASTOLDI GL GENTILINI I COSER P GALLO E PILERI A CANTONETTI M PAPA G DINI D MORANDI S BIANCHINI E PINOTTI G VENCO A ZAGONEL V PINTO A CAPALDI A GIOVANNELLI E PIZZUTI M RICCIUTI F AMBROSETTI A CAJOZZO A LOMBARDO M TORLONTANO G DELFINI C LUCARELLI G GIRINO M ASCARI E RISSO M DAMASIO E MARTINO S PARDINI S LONGINOTTI M MIRAGLIA E DEBIASE R NARDELLI S GALIENI P DISPENSA E ABBADESSA A BRUZZESE L PROSSOMARITI L CIMINO R DEROSA C GABBAS A FRANCESCO S GALLAMINI A DIFRANCESCO A QUAGLINO D MUSOLINO C SQUADRITO G AVANZINI P GOBBI F NUOVA ASM EMILIA R SAGLIO G AGLIETTA M CAMASCHELLA C MAZZA MU GUGLIELMO P CACCIOLA E MONACO M
Citation: A. Zaccaria et al., WILL MOLECULAR-BIOLOGY CONTRIBUTE TO REFINE PROGNOSIS AND TO SELECT TREATMENT, Leukemia & lymphoma, 11, 1993, pp. 81-89
TREATMENT OF PH-POSITIVE CHRONIC MYELOID-LEUKEMIA WITH ALPHA-INTERFERON (ROFERON-A) - THE ITALIAN COOPERATIVE STUDY-GROUP EXPERIENCE
Authors: TURA S RUSSO D ZUFFA E FANIN R PATRIARCA F FIACCHINI M BACCARANI M TESTONI N ZAMAGNI MD ZACCARIA A MONTEFUSCO E ALIMENA G MELONI G MANDELLI F DAMIANI D MICHIELI M CRISCUOLO D FOWST C HOLDENER EE SPECCHIA G LISO V MORRA E BERNASCONI C DEMILIO A BATTISTA R DITUCCI A BROCCIA G MAIOLINO I CARONIA F LUCIANO L ROTOLI B LEONI P DANIELI G BODENIZZA CA CAROTENUTO M ROTONDO SG NOSARI A DECATALDO F MONTUORO A DELAURENZI A CAMILLO S LIBERATI AM GRIGNANI F TABILIO A RAMBALDI A BARBUI T LEONI F CIOLLI S RONCA F NOBILE F PAOLINO F RESEGOTTI L PAPINESCHI F SPREMOLLA G LANDOLFI R LEONE G VOLPE E MANGONI L RIZZOLI V CAPUCCI A IZZI T SCAPOLI GL CASTOLDI GL GENTILINI I COSER P GALLO E PILERI A CANTONETTI M PAPA G DINI D DIPRISCO U MORANDI S BIANCHINI E PINOTTI G VENCO A ZAGONEL V PINTO A CAPALDI A GIOVANNELLI E PIZZUTI M RICCIUTI F AMBROSETTI A PERONA G PERRICONE R CAJOZZO A LOMBARDO M TORLONTANO G DELFINI C LUCARELLI G GIRINO M ASCARI E RISSO M DAMASIO E MARTINO S PARDINI S LONGINOTTI M MIRAGLIA E DEBIASE R NARDELLI S CICCONE F GALIENI P DISPENSA E ABBADESSA A BRUZZESE L PROSSOMARITI L CIMINO R DEROSA C GABBAS A FRANCESCO S GALLAMINI A DIFRANCESCO A QUAGLINO D MUSOLINO C SQUADRITO G AVANZINI P GOBBI F NUOVA ASM EMILIA R SAGLIO G AGLIETTA M CAMASCHELLA C MAZZA MU GUGLIELMO P CACCIOLA E MONACO M
Citation: S. Tura et al., TREATMENT OF PH-POSITIVE CHRONIC MYELOID-LEUKEMIA WITH ALPHA-INTERFERON (ROFERON-A) - THE ITALIAN COOPERATIVE STUDY-GROUP EXPERIENCE, Leukemia & lymphoma, 11, 1993, pp. 153-157
EVALUATING SURVIVAL AFTER ALLOGENEIC BONE-MARROW TRANSPLANT FOR CHRONIC MYELOID-LEUKEMIA IN CHRONIC PHASE - A COMPARISON OF TRANSPLANT VERSUS NO-TRANSPLANT IN A COHORT OF 258 PATIENTS 1ST SEEN IN ITALY BETWEEN1984 AND 1986
Authors: TURA S FANIN R RUSSO D ZUFFA F FIACCHINI M BACCARANI M TESTONI N ZAMAGNI D ZACCARIA A DAMIANI D MICHIELI M ALIMENA G MONTEFUSCO E MANDELLI F MORRA E BERNASCONI C GUGLIELMI P CACCIOLA E BATTISTA R DINI E SPECCHIA G LISO V MAJOLINO I CARONIA F LEONI P DANIELI G NOSARI A DECATALDO F PAOLINO F RESEGOTTI L COMOTTI B BARBUI T SCAPOLI GL CASTOLDI GL PROSSOMARITI L MONTUORI R RICCARDI A ASCARI E LANDOLFI R BIZZI B LOMBARDO M TORLONTANO G LEONI F FERRINI PR SPARAVENTI G DELFINI C PAPINESCHI F SPREMOLLA G BROCCIA G NARDELLI S CICCONE F DERIU L MIRAGLIA E DEBIASE R BODENIZZA CA CAROTENUTO M ROTONDO SG GENTILINI I COSER P CAPUCCI A IZZI T LUCIANO L ROTOLI B IACOPINO P NOBILE F CANTONETTI M PAPA G PINOTTI G SALA G FOA P MAIOLO MT AVANZINI P GOBBI F DORE F PARDINI S AMBROSETTI A PERONA G DINI D LIBERATI AM MARTELLI M GRIGNANI F MONTUORO A DELAURENZI A GALLO E PILERI A GALLAMINI A BUFFA F ABBADESSA A BRUZZESE L DEROSA C CIMINO R MANGONI L RIZZOLI V PIZZUTI M RICCIUTI F GALIENI P DISPENSA E ZAGONEL V PINTO A MUSOLINO C SQUADRITO G PERRICONE R CAJOZZO A MORANDI S BIANCHINI E MILIANI A MONACO M DIFRANCESCO A QUAGLINO D ROSTI G MARANGOLO M PASINI FL DIPERRI T AGLIETTA M GAVOSTO F
Citation: S. Tura et al., EVALUATING SURVIVAL AFTER ALLOGENEIC BONE-MARROW TRANSPLANT FOR CHRONIC MYELOID-LEUKEMIA IN CHRONIC PHASE - A COMPARISON OF TRANSPLANT VERSUS NO-TRANSPLANT IN A COHORT OF 258 PATIENTS 1ST SEEN IN ITALY BETWEEN1984 AND 1986, British Journal of Haematology, 85(2), 1993, pp. 292-299
Risultati: 1-19 |